Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...
The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.
Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and ...
Agreement grants access to Synaffix patent portfolio related to metal-free click chemistry Technology to be used in Illumina's next-generation sequencing (NGS) products AMSTERDAM, Dec. 4, 2024 ...
San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
Discover GRAIL’s MCED screening tests, Illumina’s divestiture impact, and an $8B valuation base with TAM upside tied to FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results